Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease

Fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease

US Patent 10894817 · Granted Jan 19, 2021

Estimated economic value: $1,809,151,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of using a GIP/GLP1 co-agonist for diabetes2025
Incretin analogs and uses thereof2025
Incretin analogs and uses thereof2025
Incretin analogs and uses thereof2025
Incretin analogs and uses thereof2025
Incretin analogs and uses thereof2025
Method of using a GIP/GLP1 co-agonist for diabetes2025
GIP/GLP1 co-agonist compounds2025
Long acting amylin receptor agonists and uses thereof2024
Long acting amylin receptor agonists and uses thereof2024
Injectable photothermal hydrogel based on melanin, preparation method, and appli2024
GIPR-agonist compounds2024